Table of Contents
The Emerging 5 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Features and benefits
* Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
* Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with forecasts
* Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
These countries contributed $144.6 billion to the global pharmaceuticals industry in 2014, with a compound annual growth rate (CAGR) of 15.6% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $269.9 billion in 2019, with a CAGR of 13.3% over the 2014-19 period.
Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $94.4 billion in 2014. This was followed by Brazil and India with a value of $17.8 and $16.0 billion, respectively.
China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $191.3 billion in 2019, followed by India and Brazil with expected values of $33.4 and $24.9 billion, respectively.
Your key questions answered
* What was the size of the emerging five pharmaceuticals market by value in 2014?
* What will be the size of the emerging five pharmaceuticals market in 2019?
* What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
* How has the market performed over the last five years?
* Who are the top competitors in the emerging five pharmaceuticals market?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...